Detalles de la búsqueda
1.
Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell-Targeted Therapy in the Trial of Anti-B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS).
Arthritis Rheumatol
; 2023 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38073013
Resultados
1 -
1
de 1
1
Próxima >
>>